Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases?

被引:59
作者
Arababadi, Mohammad Kazemi [1 ]
Nosratabadi, Reza [2 ]
Hassanshahi, Gholamhossein [1 ]
Yahini, Narges [3 ]
Pooladvand, Vahid [3 ]
Shamsizadeh, Ali [4 ]
Hakimi, Hamid [1 ]
Derakhshan, Reza [5 ]
机构
[1] Rafsanjan Univ Med Sci, Fac Med, Dept Microbiol Hematol & Immunol, Rafsanjan, Iran
[2] Islamic Azad Univ, Fac Med, Dept Lab Sci, Zahedan Branch, Zahedan, Iran
[3] Rafsanjan Univ Med Sci, Fac Med, Dept Biochem, Rafsanjan, Iran
[4] Rafsanjan Univ Med Sci, Fac Med, Dept Physiol, Rafsanjan, Iran
[5] Rafsanjan Univ Med Sci, Ali Ebne Abitaleb Hosp, Rafsanjan, Iran
关键词
IFN-gamma; IL-17A; Diabetes; Nephropathy; NECROSIS-FACTOR-ALPHA; INTERFERON-GAMMA; TNF-ALPHA; T-CELLS; SERUM; CYTOKINES; INTERLEUKIN-17; INDUCTION; MELLITUS; PROFILE;
D O I
10.1016/j.diabres.2009.09.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The impact of several environmental and genetic factors on diabetes and its complications is well documented. The present study was aimed to examine the serum levels of IL-17A and IFN-gamma as antagonistic cytokines in nephropathic and non-nephropathic type-2 diabetic patients. in this experimental study, serum samples were obtained from 180 type-2 diabetic patients, 100 nephropathic type-2 diabetic patients and 100 healthy controls. Serum levels of IL-17A and IFN-gamma was detected by ELISA. Results of this study showed that the serum level of IFN-gamma was higher in both diabetic patients (nephropathic and non-nephropathic) in comparison to the controls. In terms of IL-17A, while non-nephropathic type-2 diabetic patients showed an increased serum level of it, the other patients group had a lower serum level. Based on these findings, it can be concluded that the lower serum level of IL-17A is possibly associated with nephropathic complications of type-2 diabetes. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:33 / 37
页数:5
相关论文
共 27 条
[1]  
[Anonymous], P NUTR SOC
[2]  
Antonysamy MA, 1999, J IMMUNOL, V162, P577
[3]   Is CCR5-Δ32 mutation associated with diabetic nephropathy in type 2 diabetes? [J].
Arababadi, Mohammad K. ;
Naghavi, Nima ;
Hassanshahi, Gholamhossein ;
Mahmoodi, Mehdi .
ANNALS OF SAUDI MEDICINE, 2009, 29 (05) :413-413
[4]  
Arababadi MK, 2009, IRAN J BASIC MED SCI, V12, P100
[5]   GAMMA-INTERFERON INDUCTION IN PATIENTS WITH CHRONIC PROGRESSIVE MS [J].
BEVER, CT ;
PANITCH, HS ;
LEVY, HB ;
MCFARLIN, DE ;
JOHNSON, KP .
NEUROLOGY, 1991, 41 (07) :1124-1127
[6]   The role of interferon γ in regulation of CD4+ T-cells and its clinical implications [J].
Chen, Jiezhong ;
Liu, Xiaosong .
CELLULAR IMMUNOLOGY, 2009, 254 (02) :85-90
[7]  
Cooke Anne, 2006, Review of Diabetic Studies, V3, P72, DOI 10.1900/RDS.2006.3.72
[8]   Glycine treatment decreases proinflammatory cytokines and increases interferon-γ in patients with Type 2 diabetes [J].
Cruz, M. ;
Maldonado-Bernal, C. ;
Mondragon-Gonzalez, R. ;
Sanchez-Barrera, R. ;
Wacher, N. H. ;
Carvajal-Sandoval, G. ;
Kumate, J. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2008, 31 (08) :694-699
[9]   Monocytes from type 2 diabetic patients have a pro-inflammatory profile -: 1,25-Dihydroxyvitamin D3 works as anti-inflammatory [J].
Giulietti, Annapaula ;
van Etten, Evelyne ;
Overbergh, Lut ;
Stoffels, Katinka ;
Bouillon, Roger ;
Mathieu, Chantal .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 77 (01) :47-57
[10]   The effects of tolerance on allograft damage caused by the innate immune system [J].
Hoerbelt, Ruediger ;
Benjamin, Christopher L. ;
Shoji, Tsuyoshi ;
Houser, Stuart L. ;
Muniappan, Ashok ;
Hasse, Rebecca S. ;
Ledgerwood, Levi G. ;
Allan, James S. ;
Sachs, David H. ;
Madsen, Joren C. .
TRANSPLANTATION, 2008, 85 (03) :314-322